The stock of Globe Life (NYSE:GL, 30-year Financials) appears to be fairly valued, according to GuruFocus Value calculation. GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. If the price of a stock is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher. At its current price of $103.61 per share and the market cap of $12 billion, Globe Life stock is estimated to be fairly valued. GF Value for Globe Life is shown in the chart below.
Because Globe Life is fairly valued, the long-term return of its stock is likely to be close to the rate of its business growth, which averaged 8.2% over the past three years and is estimated to grow 4.75% annually over the next three to five years.
Link: These companies may deliever higher future returns at reduced risk.
It is always important to check the financial strength of a company before buying its stock. Investing in companies with poor financial strength have a higher risk of permanent loss. Looking at the cash-to-debt ratio and interest coverage is a great way to understand the financial strength of a company. Globe Life has a cash-to-debt ratio of 0.05, which is in the bottom 10% of the companies in Insurance industry. The overall financial strength of Globe Life is 4 out of 10, which indicates that the financial strength of Globe Life is poor. This is the debt and cash of Globe Life over the past years:
It is less risky to invest in profitable companies, especially those with consistent profitability over long term. A company with high profit margins is usually a safer investment than those with low profit margins. Globe Life has been profitable 10 over the past 10 years. Over the past twelve months, the company had a revenue of $4.9 billion and earnings of $7.01 a share. Its operating margin is 0.00%, which ranks in the bottom 10% of the companies in Insurance industry. Overall, the profitability of Globe Life is ranked 7 out of 10, which indicates fair profitability. This is the revenue and net income of Globe Life over the past years:
Growth is probably the most important factor in the valuation of a company. GuruFocus research has found that growth is closely correlated with the long term stock performance of a company. A faster growing company creates more value for shareholders, especially if the growth is profitable. The 3-year average annual revenue growth of Globe Life is 8.2%, which ranks better than 66% of the companies in Insurance industry. The 3-year average EBITDA growth rate is 6%, which ranks in the middle range of the companies in Insurance industry.
One can also evaluate a company's profitability by comparing its return on invested capital (ROIC) to its weighted average cost of capital (WACC). Return on invested capital (ROIC) measures how well a company generates cash flow relative to the capital it has invested in its business. The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. If the return on invested capital exceeds the weighted average cost of capital, the company is likely creating value for its shareholders. During the past 12 months, Globe Life's ROIC is 3.94 while its WACC came in at 8.00. The historical ROIC vs WACC comparison of Globe Life is shown below:
In closing, The stock of Globe Life (NYSE:GL, 30-year Financials) is believed to be fairly valued. The company's financial condition is poor and its profitability is fair. Its growth ranks in the middle range of the companies in Insurance industry. To learn more about Globe Life stock, you can check out its 30-year Financials here.
To find out the high quality companies that may deliever above average returns, please check out GuruFocus High Quality Low Capex Screener.
